Results 101 to 110 of about 912,126 (302)
Clinical Pharmacology &Therapeutics, EarlyView.Low‐dose aspirin is no longer routinely recommended for the primary prevention of cardiovascular disease in older adults due to a lack of net benefit over bleeding risk. We hypothesized that genetic subgroups may experience differential harm or benefit from aspirin therapy.
Peter D. Fransquet +8 more
wiley +1 more source
Table of information on SNP loci used in Sitka spruce SNP array with data on sequence and previous mapping in white spruce.
Hayley Tumas (17735943)
core +1 more source
Pediatric new‐onset seizure‐like events: Yield of diagnostic work‐up
Epileptic Disorders, EarlyView.Abstract Objective To assess the diagnostic yield of ancillary investigations in children presenting with new‐onset seizure‐like events (SLEs) at a tertiary first seizure clinic (FSC). Methods We conducted a retrospective cohort study including 1213 children evaluated for new‐onset SLEs at a tertiary FSC.
Geertruida Slinger +8 more
wiley +1 more source
Deep whole genome sequencing of epileptogenic brain lesions
Epilepsia, EarlyView.Abstract Objective Malformations of cortical development and low‐grade epilepsy‐associated tumors often cause drug‐resistant lesional focal epilepsy (LFE) amenable to surgical treatment. Genetic testing of resected brain tissue can provide diagnostic and mechanistic information and may eventually support personalized treatment approaches.
Christian M. Boßelmann +17 more
wiley +1 more source
, 2017 SNP-SNP interaction models identified by the GMDR method with adjustment for age, gender, and education.
Chung-Feng Kao (104445) +6 more
core +1 more source
Neonatal seizures: Advances in diagnosis and management
Epilepsia Open, EarlyView.Abstract The International League Against Epilepsy (ILAE) created the ILAE Neonatal Task Force that classified neonatal seizures, defined neonatal epilepsy syndromes, and specified treatment guidelines. These frameworks, in addition to improved access to genetic testing and other recent advances, have revolutionized the diagnosis and management of ...
Elissa G. Yozawitz +2 more
wiley +1 more source
PLoS ONE, 2020 High-throughput SNP genotyping has become a precondition to move to higher precision and wider genome coverage genetic analysis of natural and breeding populations of non-model species.
Pedro Italo T Silva +5 more
doaj +1 more source
Genetic testing practices across European epilepsy centers: An ERN EpiCARE survey
Epilepsia Open, EarlyView.Abstract Objective Genetic testing plays an increasing role in the diagnostic pathway for rare and complex epilepsies. However, significant heterogeneity persists in access, implementation, and interpretation across Europe. This study aimed to assess genetic testing practices, accessibility, and challenges across expert epilepsy centers within the ...
Sébile Tchaicha +11 more
wiley +1 more source
Developing a 670k genotyping array to tag ~2M SNPs across 24 horse breeds
BMC Genomics, 2017 Background To date, genome-scale analyses in the domestic horse have been limited by suboptimal single nucleotide polymorphism (SNP) density and uneven genomic coverage of the current SNP genotyping arrays.
Robert J. Schaefer +34 more
doaj +1 more source
SNP ARRAY NEXUS BIODISCOVERY DATA
, 2019 Data output from SNP Array analyses in Nexus Copy Number v7.5 (BioDiscovery, Inc.). Data per sample includes: Calls.txt; call thresholds.txt; descriptor set; probes.ivg; raw_snps.text; raw.txt; segments.ivg; setting.xmle; snps.ivg; snpsegments.ivg ...
Keith Hunter (8030276) +39 more
core +1 more source